Viewing Study NCT06673693

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:23 AM
Ignite Modification Date: 2026-02-09 @ 7:57 AM
Study NCT ID: NCT06673693
Status: RECRUITING
Last Update Posted: 2025-04-16
First Post: 2024-10-31
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Tislelizumab Combined With SBRT for the Treatment of Head and Neck Squamous Cell Carcinoma
Sponsor: Sun Yat-sen University
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Head and Neck Squamous Cell Carcinoma (HNSCC) View
None HNSCC View
Keywords:

Keywords

Keyword Brief Keyword Text View
None SBRT View
None PD-1 antibody View
None Tislelizumab View
None Neoadjuvant Therapy View